Hilda Frederique Scharen-Guivel, Director, on June 04, 2026, sold 3,000 shares in Iradimed (IRMD) for $285,000. Following the Form 4 filing with the SEC, Scharen-Guivel has control over a total of 5,598 common shares of the company, with 5,598 shares held directly.
SEC Filing: